Five cases report of solid tumor synchronously with hematologic malignancy.

Area of Science:

• Oncology
• Hematology
• Internal Medicine

Background:

• Synchronous multiple primary cancer (SMPC) is a rare oncological condition.
• The co-occurrence of a solid tumor with a hematological malignancy is exceptionally uncommon.
• Managing concurrent malignancies presents significant therapeutic challenges due to a lack of standardized treatment protocols.

Purpose of the Study:

• To report and discuss five unique cases of synchronous solid tumors and hematological malignancies.
• To explore the clinical presentation and management of these rare co-occurring cancers.
• To contribute to the limited literature on SMPC involving both solid and hematological neoplasms.

Main Methods:

• Retrospective case series analysis.
• Review of five patient cases diagnosed with synchronous solid tumors and hematological malignancies.
• Analysis of treatment approaches and outcomes for each case.

Main Results:

• Five distinct cases of synchronous solid tumor and hematological malignancy were identified within a two-year period.
• Cases included combinations such as lung adenocarcinoma with chronic myelogenous leukemia, colon cancer with solitary plasmocytoma, gastric adenocarcinoma with diffuse large B-cell non-Hodgkin's lymphoma, lung adenocarcinoma with multiple myeloma, and colon cancer with diffuse large B-cell non-Hodgkin's lymphoma.
• Therapeutic strategies varied based on individual case specifics, reflecting the absence of a universal treatment guideline.

Conclusions:

• The simultaneous occurrence of solid tumors and hematological malignancies is a rare clinical scenario.
• Effective management requires individualized treatment plans due to the complexity and lack of established protocols.
• Further research and case reporting are crucial for developing optimal therapeutic strategies for these rare conditions.